KARPROLIS
Dead / Abandoned — Abandoned — no statement of use filed (as of 27 May 2013)
What this means for you
This application is over — abandoned 27 May 2013. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85455957
- Mark type
- Stylized text
- Filed
- 25 Oct 2011
- Published for opposition
- 28 Aug 2012
- Abandoned
- 27 May 2013
- Attorney of record
- Anne H. Peck
Goods and services
- Class 042 — Scientific and technological services: PHARMACEUTICAL RESEARCH AND DEVELOPMENT; MEDICAL AND SCIENTIFIC RESEARCH, NAMELY, CONDUCTING CLINICAL TRIALS; MEDICAL AND SCIENTIFIC RESEARCH IN THE FIELDS OF TREATMENT FOR CANCER AND ONCOLOGY, AND IN THE FIELDS OF TREATMENT OF INFLAMMATION AND AUTOIMMUNE DISEASES
Owner
- Onyx Pharmaceuticals, Inc., South San Francisco, CA, US
- Onyx Pharmaceuticals, Inc., South San Francisco, CA, US
Prosecution history
- 28 May 2013 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 27 May 2013 — ABANDONMENT - NO USE STATEMENT FILED
- 23 Oct 2012 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Aug 2012 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Aug 2012 — PUBLISHED FOR OPPOSITION
- 15 Aug 2012 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Jul 2012 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 16 Jul 2012 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Jul 2012 — EXAMINER'S AMENDMENT ENTERED
- 12 Jul 2012 — ASSIGNED TO LIE
- 12 Jul 2012 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 12 Jul 2012 — EXAMINERS AMENDMENT E-MAILED
- 12 Jul 2012 — EXAMINERS AMENDMENT -WRITTEN
- 15 Dec 2011 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 15 Dec 2011 — NON-FINAL ACTION E-MAILED